IL-10, another immunosuppressive cytokine, further contributes to the complexity of the immune landscape in liver cancer by inhibiting the synthesis of pro-inflammatory cytokines, thus reducing the effectiveness of the immune response against tumor cells. This evidence concerns the gene IL10 and liver cancer.